Le Lézard
Classified in: Health
Subjects: CHI, SVY, HSP, ASI, BLK, DEI

An Unfair Fight: How Race and Social Determinants Impact Maternal and Infant Health


PLYMOUTH MEETING, Pa., June 17, 2021 /PRNewswire/ -- ProgenyHealth, LLC, a provider of comprehensive NICU care management for premature and medically complex newborns, today announced the release of a special industry report detailing how race and social determinants impact maternal and infant health.

Entitled "An Unfair Fight" ? the comprehensive report highlights how racism relates to maternal and infant mortality rates and provides insights into how health inequities are driven beyond factors of social determinants of health. The report also urges immediate social action for health providers, health plans and policy makers.

"Though long overdue, our country is finally acknowledging a national crisis. There is a mountain of data that shows Black, Asian American, Pacific Islander, Native American, Alaska Native, and Latinx individuals are disproportionately likely to experience adverse health problems. Nowhere is this more evident than in maternal and infant health," said Ellie Stang, MD, founder and CEO of ProgenyHealth.

"An Unfair Fight" is currently available for download here.

About ProgenyHealth
ProgenyHealth, LLC, is the only national company dedicated exclusively to NICU Care Management ? utilization management, case management and payment validation and assurance services. Our board certified neonatologists, pediatric intensivists, NICU/pediatric nurses, and social workers collaborate with providers on behalf of Medicaid and commercial health plans, as well as large employers, to ensure health care services follow evidence-based best practices and are medically necessary. In 2020 alone, we solved for more than 12,000 social determinants of health issues. ProgenyHealth's integrated program has proven effective in managing nearly 100,000 NICU cases, in over 1,400 hospitals, in all 50 states. We are measurably improving health outcomes for premature and medically complex newborns and delivering quantifiable cost savings to our partners. For more information, visit www.progenyhealth.com.

Media Contact:
Linda Smith
VP, Marketing & Communications
[email protected] 
Mobile: 609.206.1552

SOURCE ProgenyHealth


These press releases may also interest you

at 07:15
mBIOTA Labs, a medical food company revolutionizing oral nutrition through their proprietary palatable elemental diet, mBIOTA Elementaltm, today announced the initial study results of their first prospective clinical trial assessing the efficacy of...

at 07:05
Beaconcure Inc., a leader in AI-enabled clinical data validation and automation, announces a strategic partnership with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical review processes in...

at 07:05
BPGbio, a leading biology-first AI-powered biopharma that focuses on oncology, neurology, and rare diseases, announced today the publication of a significant, multi-year research effort titled "Identification and validation of N-acetylputrescine in...

at 07:05
Septerna, a biotechnology company discovering and advancing novel, oral small molecule medicines targeting G protein-coupled receptors (GPCRs), today announced that the company will present the first preclinical data on the company's parathyroid...

at 07:00
In recognition of Clinical Trials Day, The Trial for #ClinicalEquality ?a longstanding and widely celebrated initiative from FCB Health New York, an IPG Health company ? continues the fight to increase equity in clinical trials with the next phase of...

at 07:00
The InterMed Group ("InterMed" or the "Company"), a leading provider of healthcare technology management services, proudly announces the appointment of Michael Koffler as its new Chief Executive Officer....



News published on and distributed by: